Woodline Partners LP - VOR BIOPHARMA INC ownership

VOR BIOPHARMA INC's ticker is VOR and the CUSIP is 929033108. A total of 50 filers reported holding VOR BIOPHARMA INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 1.6%.

Quarter-by-quarter ownership
Woodline Partners LP ownership history of VOR BIOPHARMA INC
ValueSharesWeighting
Q3 2023$2,355,581
-31.4%
1,111,1230.0%0.03%
-31.7%
Q2 2023$3,433,370
-42.6%
1,111,1230.0%0.04%
-49.4%
Q1 2023$5,977,842
-19.1%
1,111,1230.0%0.08%
-18.2%
Q4 2022$7,388,968
+67.1%
1,111,1230.0%0.10%
+59.7%
Q3 2022$4,422,000
-19.9%
1,111,1230.0%0.06%
-27.1%
Q2 2022$5,522,000
-17.7%
1,111,1230.0%0.08%
-22.0%
Q1 2022$6,711,000
-48.0%
1,111,1230.0%0.11%
-41.1%
Q4 2021$12,911,000
-25.9%
1,111,1230.0%0.18%
-34.9%
Q3 2021$17,422,000
-18.5%
1,111,123
-3.1%
0.28%
-28.8%
Q2 2021$21,382,000
-57.0%
1,146,494
-0.6%
0.40%
-63.8%
Q1 2021$49,706,0001,153,2671.10%
Other shareholders
VOR BIOPHARMA INC shareholders Q1 2021
NameSharesValueWeighting ↓
5AM Venture Management, LLC 6,361,723$34,226,0708.75%
OUP Management Co., LLC 374,714$2,015,9614.02%
Paradigm Biocapital Advisors LP 6,477,999$34,851,6353.30%
RA Capital Management 22,748,880$122,388,9742.77%
JOHNSON & JOHNSON 1,074,658$5,781,6601.88%
Artal Group S.A. 2,792,805$15,0250.89%
Trustees of Columbia University in the City of New York 91,910$494,4760.88%
Sarissa Capital Management LP 618,000$3,324,8400.42%
Laurion Capital Management LP 3,182,889$17,123,9430.12%
Woodline Partners LP 1,111,123$5,977,8420.08%
View complete list of VOR BIOPHARMA INC shareholders